Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

November 9, 2007
Date of Report (Date of Earliest Event Reported)

 
Neurologix, Inc.
 
(Exact name of Registrant as Specified in its Charter)

 

 Delaware
 000-13347
 06-1582875
 (State or other Jurisdiction
 (Commission File Number)
 (I.R.S. Employer Identification No.)
 of Incorporation or Organization)
    
                                                                                              
                                                    
 

One Bridge Plaza, Fort Lee, New Jersey 07024
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:  (201) 592-6451


(Former Name or Former Address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
□
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
□
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
□
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 
Item 2.02  Results of Operations and Financial Condition.
 
On November 9, 2007, Neurologix, Inc. issued a press release announcing its financial results for the third quarter and nine months ended September 30, 2007.  The entire text of the press release is attached as Exhibit 99.1 and is incorporated by reference herein.
 
Item 9.01 Financial Statements and Exhibits.
 
(d)           Exhibits
 
99.1  Neurologix, Inc. Press Release dated November 9, 2007.
 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto, duly authorized.
 
 
  NEUROLOGIX, INC.  
       
Date:  November 9, 2007
By:
/s/ Marc L. Panoff   
    Name:  Marc L. Panoff  
    Title:  Chief Financial Officer, Secretary and Treasurer